Biomedical Product Design & Development


Director:
Sara Wilson, Ph.D.

Design and development of new medical products requires advanced bioengineering expertise as well as an understanding of clinical applications, business considerations and regulatory aspects of the medical field. Advanced engineering skills must interface with clinical needs and requirements.

The Biomedical Product Design and Development Track combines graduate-level research and coursework with practical exposure to these clinical, business and regulatory processes in a professional, collaborative environment.

Students use their new understanding of market-driven forces to plan and execute their research with end-driven methods and an understanding of how their research results could be applied to development of a biomedical product. They not only work with their own basic and applied research, but also with other researchers in the KU Bioengineering community.

Medical products to be developed can include diagnostic tools, interventional and therapeutic devices, imaging equipment and methods, and biomaterials. This track includes a course in biomedical product development to introduce basic concepts of design, quality system regulations, regulatory aspects and entrepreneurship.

Required courses in engineering design methods teach students how to successfully complete applied research. A clinical or industrial preceptorship is required to give students practical exposure to applied biomedical research and development. Students completing this track will be prepared to apply their product-driven education either in industrial research and development, in a regulatory agency, or in academia interfacing with industry.

 

An accessible version of the content below will be made available upon request. Please contact bioe@ku.edu to request the content be made available in an accessible format.

Track Faculty

Sue Lunte
  • -Ralph N. Adams Distinguished Professor of Chemistry and Pharmaceutical Chemistry
  • -Director, Adams Institute for Bioanalytical Chemistry
  • -Director, NIH COBRE Center for Molecular Analysis of Disease Pathways